Juergen Prattes

1.1k total citations
16 papers, 308 citations indexed

About

Juergen Prattes is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juergen Prattes has authored 16 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 12 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juergen Prattes's work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (9 papers) and Nail Diseases and Treatments (3 papers). Juergen Prattes is often cited by papers focused on Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (9 papers) and Nail Diseases and Treatments (3 papers). Juergen Prattes collaborates with scholars based in Austria, United States and Germany. Juergen Prattes's co-authors include Robert Krause, Martin Hoenigl, Thomas Valentin, Ines Zollner‐Schwetz, Rosa Bellmann‐Weiler, Oskar Janata, Jeffrey D. Jenks, Matthias Egger, Jessica S. Price and P. Lewis White and has published in prestigious journals such as Journal of Clinical Microbiology, Frontiers in Immunology and The Lancet Infectious Diseases.

In The Last Decade

Juergen Prattes

16 papers receiving 303 citations

Peers

Juergen Prattes
Miguel Sierra‐Hoffman United States
Gema Fresco Spain
Orla Morrissey Australia
Mark Wissel United States
María José Linares-Sicilia Spain
Lauro Damonti Switzerland
Silvana Sanna Italy
Chhavi Gupta India
Ai Ling Tan Singapore
Sara Mazzanti Italy
Miguel Sierra‐Hoffman United States
Juergen Prattes
Citations per year, relative to Juergen Prattes Juergen Prattes (= 1×) peers Miguel Sierra‐Hoffman

Countries citing papers authored by Juergen Prattes

Since Specialization
Citations

This map shows the geographic impact of Juergen Prattes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juergen Prattes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juergen Prattes more than expected).

Fields of papers citing papers by Juergen Prattes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juergen Prattes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juergen Prattes. The network helps show where Juergen Prattes may publish in the future.

Co-authorship network of co-authors of Juergen Prattes

This figure shows the co-authorship network connecting the top 25 collaborators of Juergen Prattes. A scholar is included among the top collaborators of Juergen Prattes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juergen Prattes. Juergen Prattes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hoenigl, Martin, Matthias Egger, Jessica S. Price, et al.. (2023). Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis. Journal of Clinical Microbiology. 61(3). e0185922–e0185922. 33 indexed citations
2.
Prattes, Juergen, Thomas King, Nkechi Azie, & David Angulo. (2022). P057 All- cause mortality in patients with invasive Candidiasis or candidemia from an interim analysis of a Phase 3 Open-label Study (FURI). Medical Mycology. 60(Supplement_1). 1 indexed citations
3.
Thompson, George R., Thomas King, Nkechi Azie, David Angulo, & Juergen Prattes. (2022). 871. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI). Open Forum Infectious Diseases. 9(Supplement_2). 13 indexed citations
4.
Prattes, Juergen, Thomas King, Nkechi Azie, & David Angulo. (2022). P056 Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI). Medical Mycology. 60(Supplement_1). 5 indexed citations
5.
Prattes, Juergen, Thomas King, Nkechi Azie, & David Angulo. (2022). 466. All-Cause Mortality in Patients with Invasive Candidiasis or Candidemia from an Interim Analysis of a Phase 3 Open-label Study (FURI). Open Forum Infectious Diseases. 9(Supplement_2). 3 indexed citations
6.
Oulhaj, Abderrahim, Ahmed R. Alsuwaidi, Junu A. George, et al.. (2021). Admission levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) are Associated with the Development of Severe Complications in Hospitalised COVID-19 Patients: A Prospective Cohort Study. International Journal of Infectious Diseases. 107. 188–194. 21 indexed citations
7.
Reisinger, Alexander C., Gernot Schilcher, Juergen Prattes, Ines Zollner‐Schwetz, & Philipp Eller. (2020). Acute respiratory distress syndrome during a pandemic—an obvious diagnosis?. The Lancet Infectious Diseases. 20(7). 873–873. 1 indexed citations
8.
Jenks, Jeffrey D., Marisa H. Miceli, Juergen Prattes, Toine Mercier, & Martin Hoenigl. (2020). The Aspergillus Lateral Flow Assay for the Diagnosis of Invasive Aspergillosis: an Update. Current Fungal Infection Reports. 14(4). 378–383. 27 indexed citations
9.
Vehreschild, Jörg Janne, Philipp Koehler, Frédéric Lamoth, et al.. (2020). Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients. Medical Mycology. 59(1). 93–101. 4 indexed citations
10.
11.
Krause, Robert, Thomas Valentin, Juergen Prattes, et al.. (2019). Multicenter clinical experience of real life Dalbavancin use in gram-positive infections. International Journal of Infectious Diseases. 81. 210–214. 101 indexed citations
12.
Rawlings, Stephen A., Sven Heldt, Juergen Prattes, et al.. (2019). Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection. Frontiers in Immunology. 10. 1798–1798. 23 indexed citations
13.
Zurl, Christoph, Juergen Prattes, Ines Zollner‐Schwetz, et al.. (2019). T2Candida magnetic resonance in patients with invasive candidiasis: Strengths and limitations. Medical Mycology. 58(5). 632–638. 17 indexed citations
14.
Salzer, Helmut J.F., Juergen Prattes, Holger Flick, et al.. (2018). Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis. Frontiers in Microbiology. 9. 2223–2223. 24 indexed citations
15.
Zurl, Christoph, Geza Gemes, Martin Mitteregger, et al.. (2018). Serum 1,3-Beta-D-Glucan Values During and After Laparoscopic and Open Intestinal Surgery. Open Forum Infectious Diseases. 5(12). ofy296–ofy296. 17 indexed citations
16.
Prattes, Juergen, Thomas Orasch, Susanne Eigl, et al.. (2016). Diagnostic Performance Of Bronchoalveolar Lavage Triacetylfusarinine C (TAFC) Determination for Invasive Pulmonary Aspergillosis In Patients With Hematological Malignancies. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miguel Sierra‐Hoffman Breakdown of academic impact, for papers by Gema Fresco Breakdown of academic impact, for papers by Orla Morrissey Breakdown of academic impact, for papers by Mark Wissel Breakdown of academic impact, for papers by María José Linares-Sicilia Breakdown of academic impact, for papers by Lauro Damonti Breakdown of academic impact, for papers by Silvana Sanna Breakdown of academic impact, for papers by Chhavi Gupta Breakdown of academic impact, for papers by Ai Ling Tan Breakdown of academic impact, for papers by Sara Mazzanti
Rankless by CCL
2026